Omada Health, INC Form 4 insider transactions

Omada Health President Wei-Li Shao has sold shares of common stock as part of a pre-arranged trading plan, with an amendment correcting the number of shares sold and beneficially owned.

Omada Health's Chief Financial Officer, Steven L. Cook, has reported the sale of 17,950 shares of common stock under a pre-arranged 10b5-1 trading plan.

Omada Health Chief Accounting Officer Craig Gracey sold 2,083 shares of common stock for $18 per share, totaling $37,494, under a pre-established 10b5-1 trading plan.

Omada Health Director Trevor Fetter reported transactions involving restricted stock units and common stock.

Omada Health Director Jeryl L. Hilleman acquired 10,882 shares of common stock through restricted stock units.

Omada Health Director Adam Stavisky acquired 10,882 shares of common stock through restricted stock units.

Omada Health Director Jonathan D. Root acquired 10,882 shares of common stock through restricted stock units.

Omada Health Director Julie D. Klapstein acquired 10,882 shares of common stock through restricted stock units.

Omada Health Director Anne Beal acquired 10,882 shares of common stock through restricted stock units.

Sachin H. Jain, a Director at Omada Health, Inc., acquired 10,882 restricted stock units on June 16, 2026.

Omada Health CEO Sean P. Duffy reported a transaction involving the sale of common stock, executed under a pre-arranged 10b5-1 trading plan.

Omada Health's Chief Financial Officer, Steven L. Cook, sold 6,800 shares of common stock for a weighted average price of $17.2329 per share under a pre-arranged 10b5-1 trading plan.

Chief Accounting Officer Craig Gracey sold 6,894 shares of Omada Health common stock on June 12, 2026.

President Wei-Li Shao sold 4,589 shares of Omada Health common stock via a pre-arranged 10b5-1 trading plan.

CEO Sean Duffy executed a tax-related share disposition and a gift of common stock, adjusting his direct holdings in Omada Health.

Omada Health CFO Steven L. Cook disposed of 2,010 shares of common stock to cover tax obligations.

Omada Health President Wei-Li Shao disposed of 1,843 shares of common stock to satisfy tax withholding obligations.

Omada Health's Chief Financial Officer, Steven L. Cook, reported a sale of 4,493 shares of common stock on June 1, 2026.

Omada Health Chief Accounting Officer Craig Gracey reported a sale of 385 shares of common stock on June 1, 2026, for $18.38 per share.

Omada Health, Inc. reports a significant stock sale by President Wei-Li Shao.

Sean P. Duffy, CEO and Director of Omada Health, Inc., reported a transaction involving the sale of 9,884 shares of common stock.

Omada Health President Wei-Li Shao sold 2,829 shares of common stock for approximately $36,000 under a pre-arranged 10b5-1 trading plan.

Jeryl L. Hilleman, a Director at Omada Health, Inc., acquired 1,544 shares of common stock on April 5, 2026, as part of the company's Non-Employee Director Compensation Program.

Omada Health Director Jonathan D. Root acquired 882 shares of common stock through restricted stock units granted under the company's Non-Employee Director Compensation Program.

Omada Health Director Julie D. Klapstein acquired 698 shares of common stock through restricted stock units granted under the company's Non-Employee Director Compensation Program.

Omada Health Director Trevor Fetter has reported transactions involving restricted stock units and common stock, including the acquisition of RSUs in lieu of fees and a transfer of shares to a family trust.

Omada Health's Chief Financial Officer, Steven L. Cook, sold 1,884 shares of common stock for $13.94 per share under a pre-arranged 10b5-1 trading plan.

Omada Health's Chief Accounting Officer, Craig Gracey, was granted 16,470 restricted stock units, vesting quarterly over four years starting March 1, 2026.

Omada Health's Chief Financial Officer, Steven L. Cook, was granted 147,058 restricted stock units, vesting quarterly over four years.

Omada Health's President, Wei-Li Shao, was granted 264,705 restricted stock units, aligning executive incentives with long-term company performance.